Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea · Delayed Price · Currency is KRW 38,850
-150 (-0.38%)
At close: Sep 11, 2026
Chong Kun Dang Holdings Market Cap
Chong Kun Dang Holdings has a market cap or net worth of 184.95 billion as of September 11, 2026. Its market cap has decreased by -20.88% in one year.
Market Cap
184.95B
Enterprise Value
911.28B
Revenue
961.64B
Ranking
n/a
PE Ratio
3.55
Stock Price
38,850.00
ChartMarket Cap Chart
Since July 9, 1992, Chong Kun Dang Holdings's market cap has increased from 43.10B to 184.95B, an increase of 329.09%. That is a compound annual growth rate of 4.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 184.95B | -16.00% |
| Dec 30, 2025 | 220.18B | -3.04% |
| Dec 30, 2024 | 227.08B | -19.63% |
| Dec 28, 2023 | 282.55B | 9.42% |
| Dec 29, 2022 | 258.23B | -31.93% |
| Dec 30, 2021 | 379.33B | -40.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 227.38B |
| HLB Pharmaceutical | 216.47B |
| Yungjin Pharm. | 196.24B |
| Whan In Pharm | 190.94B |
| REYON Pharmaceutical | 185.06B |
| BNC KOREA | 179.54B |
| AptaBio Therapeutics | 178.39B |
| FutureChem Co.,Ltd | 175.57B |